Objective To evaluate the effectiveness and safety of different doses of interferon alfa (INF-α) in the treatment of chronic hepatitis C (CHC). Methods Such databases as MEDLINE, EMbase, CENTRAL, CBM, CNKI, VIP and WanFang Data were searched to collect the randomized controlled trials (RCTs) on different doses of INF-α in the treatment of CHC published before August, 2012. According to the inclusion and exclusion criteria, two reviewers independently screened literature, extracted data and evaluated the quality of the included studies, and then meta-analysis was performed using RevMan 5.0 software. Results A total of 13 RCTs involving 1 442 patients were included. The results of meta-analysis on different doses of INF-α showed that, a) There was no significant difference in the complete response rate between the 3 MU dose group and the 1 MU dose group (RR=0.83, 95%CI 0.52 to 1.32, P=0.43), but there was significant difference in the sustained response rate between those 2 groups (RR=1.89, 95%CI 1.00 to 3.59, P=0.05); and b) No significant differences were found in the complete response rate among the 3 MU dose group, the 6 MU dose group, and the 1 MU dose group. Conclusion INF-α in dose of 3 MU, 3 times daily, is effective in treating CHC, but it would not rule out that higher dose takes more effective action. When INF-α is used to treat CHC, an individualized medication should be applied according to patients’ tolerance and economic status.
Objective To explore the feasibility of children age dependent chest tube voltage settings for optimizing radiation dose and image quality in digital radiography (DR). Methods Children aged 0 to 14 who visited the First Affiliated Hospital of Xinjiang Medical University from January, 2008 to December, 2010, were divided into the following 5 age groups: 0~, 1~, 3~, 7~, and 11~14-year-old, and each group was then randomly assigned to the optimization and control groups to take DR by computer. DR in automatic exposure control with different tube voltage depending on children age; the control group: DR in automatic exposure control with conventional fixed tube voltage. The dose area product (DAP) was adopted for the measurement of radiation dose, while the visual grading analysis score (VGAS) was for image quality. Then SPSS 17.0 was applied for statistical analysis. Results A total of 2 450 children were initially included. Finally there were 2 415 children included in the anteroposterior chest image in this study, and the other 35 children were excluded for their anatomical characteristics could not be showed due to serious primary diseases. There were 1 202 patients in the optimization group and 1 213 patients in the controlled group. The mean DAP in the optimization group was lower than that in the control group with a significant difference (t= –4.967, P=0.008). The mean VGAS in the optimization group was higher than that in the control group with a significant difference (t= 23.738, P=0.000). Conclusion Children age dependent tube voltage settings can effectively reduce radiation dose and improve image quality at the same time.
Objective To systematically evaluate the effectiveness of N-acetylcysteine (NAC) combined with low-dose glucocorticoid for patients with idiopathic pulmonary fibrosis (IPF). Methods Such databases as The Cochrane Library (Issue 12, 2012), EMbase (January 1974 to July 2012), PubMed (January 1966 to July 2012), CHEST (January 1995 to July 2012), CNKI (January 1994 to July 2012), CBM (January 1978 to July 2012), VIP (January 1989 to July 2012) and WanFang Data (January 1995 to July 2012) were searched to collect the randomized controlled trials (RCTs) about NAC combined with low-dose glucocorticoid versus glucocorticoid alone for IPF patients. Two reviewers independently screened the literature according to the inclusion and exclusion criteria, extracted the data, and assessed the quality, and then the meta-analysis was performed using RevMan 5.1 software. Results A total of seven RCTs including 264 IPF patients were included. The results of meta-analysis demonstrated that, compared with the glucocorticoid used alone, a) NAC combined with low-dose glucocorticoid could significantly improve PaO2 (SMD=0.82 mmHg, 95%CI 0.30 to 1.35, P=0.002) and DLco (SMD=0.59 mmHg, 95%CI 0.16 to 1.03, P=0.008) with a significant difference. b) NAC combined with low-dose glucocorticoid could significantly improve all clinical symptoms (RR=1.56, 95%CI 1.26 to 1.92, Plt;0.000 1). Conclusion NAC combined with low-dose glucocorticoid for IPF patients can significantly improve PaO2, DLco, and the clinical symptoms such as cough, difficulty breathing after activities, cyanosis, and Velcro rales. Due to the quantity and quality limitation of included studies, this conclusion still needs to be further proved by more high quality and double blind RCTs.
What drug dosage range is appropriate for treatment? What drug dosage range can maximally reduce the incidence of adverse drug reaction (ADR)? The gold zone method as a new method of evidence-based medical research was proposed to study those two blind areas of drug dosage in this article. Studying the dose-effect relationship, taking gold zone as the middle range and dividing empirical range into 3 sections were the key to study design. The evidence-based survey with extremely large sample showed a U-shaped rule existing between the antibiotics’ dosage and the incidence of ADR; and the dosage in gold zone appeared at the bottom of U-shaped curve. The gold zone method for determining dosage is a special breakthrough currently for solving those two blind areas of drug dosage
Objective To assess the effectiveness and safety of high-dose chemotherapy assisted with autologous peripheral blood stem cell treatment (APBSCT+HDC) for small cell lung cancer (SCLC). Methods The databases such as MEDLINE (1970 to January 2011), EMBASE (1980 to January 2011), Science Direct (1980 to January 2011), The Cochrane Library (Issue 3, 2010), CNKI (from the date of establishment to December 2010), CBM (from the date of establishment to December 2010) and Wanfang database (from the date of establishment to December 2010) were searched for collecting randomized controlled trials (RCTs) on APBSCT+HDC for SCLC. According to the inclusive and exclusive criteria, the trials were screened, the data were extracted, the methodological quality was assessed, and then Meta-analysis was conducted by using RevMan 5.0 software. Results A total of 6 RCTs involving 737 patients with SCLC were included. The results of Meta-analyses were as follows: the APBSCT+HDC for SCLC was significantly superior to the conventional chemotherapy in the total effective rate (RR=1.14, 95%CI 1.07 to 1.21, Plt;0.000 1) and the overall survival rate (RR=3.74, 95%CI 2.13 to 6.58, Plt;0.000 01), and it was superior in reducing the incidence of III/IV grade red blood cell reduction (RR=1.97, 95%CI 1.15 to 3.38, P=0.01) and thrombopenia (RR=1.93, 95%CI 1.06 to 3.54, P=0.03) with significant differences; but there was no significant difference between the two groups in reducing the incidence of III/IV leukopenia. Conclusions Compared with the conventional chemotherapy, APBSCT+HDC treatment for SCLC can improve the overall effective rate and overall survival rate, but it can also increase the risks of severe hematologic toxic reaction. Because of the small scale and low quality of the included studies, this conclusion still needs to be confirmed by high-quality, large-scale and multi-centered RCTs.
目的 评估国际抗癫痫联盟（ILAE）耐药癫痫定义专家共识在发展中国家、发展中地区应用的可行性及应用中存在的问题。 方法 2010年12月9日－2011年2月18日，连续登记癫痫专科门诊患者409例。共纳入183例患者，根据ILAE耐药癫痫新定义对每位纳入患者癫痫分类进行评估。 结果 耐药癫痫患者18例（8.7%），临床治愈患者29例（14.1%），不能判断为159例（77.2%）。入组患者共涉及癫痫药物治疗方案321项。根据ILAE定义步骤一分类为不确定的治疗方案共有199项（62.00%），其中数量最多的为服药剂量＜50% WHO限定日剂量有157例（78.89%）。 结论 由于治疗剂量未能够达到国际统一标准，大量患者分类不明确，使得该共识应用面临巨大挑战，但目前为止该共识对于发展中地区耐药癫痫治疗有很强的指导促进意义，对未来耐药癫痫的早期识别有非常大的应用潜力。
目的 探讨全凭静脉麻醉中腺苷对丙泊酚用量的影响。 方法 2011年1月－12月期间59例行择期手术的患者全凭静脉麻醉，随机分为腺苷静脉持续输注组（A组）和对照组（B组），A组患者麻醉诱导后持续输注腺苷70 μg/（kg·min），直至术毕。B组麻醉后按常规处理。比较两组患者麻醉时间、苏醒时间、瑞芬太尼用量，麻醉过程中平均动脉压（MAP）、心率，以及麻醉过程中丙泊酚的用量。同时记录使用腺苷过程中的不良反应。 结果 两组患者麻醉时间、苏醒时间、瑞芬太尼用量比较均无明显差异，无统计学意义（P＞0.05）。两组患者麻醉过程中MAP、心率比较亦无明显差异，无统计学意义（P＞0.05）。两组患者麻醉过程中丙泊酚平均用量比较，A组明显低于C组，差异有统计学意义（P＜0.05），且不良反应发生率低。 结论 腺苷能明显降低全凭静脉麻醉中丙泊酚的使用剂量。
【摘要】 目的 评价64层螺旋CT低剂量冠状动脉血管成像的价值。 方法 2009年1-6月157例患者随机分为3组，常规剂量组（A组）管电流量采用1 000 mAs，两个低剂量组（B、C组）分别采用800、600 mAs。对3组的图像质量、噪声、CT剂量指数（CTDI）、剂量长度乘积（DLP）和有效剂量（ED）进行评估。 结果 A、B、C组图像噪声分别为20.50±3.23、23.02±3.05和26.28±2.58，组间差异均无统计学意义（Pgt;0.05）；A、B、C组的CTDI分别为（58.7±0.23）、（46.98±2.27）、（35.28±3.56） mGy，DLP分别为（1 050.88±89.63）、（846.21±57.86）、（641.13±32.15） mGy?cm，ED分别为（14.78±2.56）、（11.85±1.87）、（8.98±1.15） mSv，B、C组的CTDI、DLP、ED均明显低于常规剂量A组（Plt;0.05），C组的CTDI、DLP、ED均为3组中最低值。 结论 64层螺旋CT冠状动脉血管检查，采用600 mAs管电流量获得的冠脉图像既可满足诊断需要，又可使患者接受的辐射剂量降低。【Abstract】 Objective To evaluate the best tube current for low-dose radiation CT in coronary artery imaging by 64-slices multi-detector CT. Methods From January to June 2009, a total of 157 consecutive patients were randomly divided into 3 groups: group A (conventional group): 1 000 mAs; group B: 800 mAs; group C: 600 mAs. The image quality, noise, CT dose index (CTDI), dose length product (DLP) and effective dose (ED) in each group were measured and compared respectively. Results The image noise scores in group A, B, and C were (20.50±3.23), (23.02±3.05) and (26.28±2.58), respectively. There was no statistically significant difference among the three groups in the two indexes (Pgt;0.05). The CTDI in group A, B and C were (58.7±0.23), (46.98±2.27), and (35.28±3.56) mGy, respectively; the DLP in each were (1 050.88±89.63), (846.21±57.86), and (641.13±32.15) mGy?cm, respectively; the Ed were (14.78±2.56), (11.85±1.87), and (8.98±1.15) mSv, respectively. All of the differences among the three groups in CTDI, DLP and ED were statistically significant (Plt;0.05). Conclusion The image with 600 mAs as tube current in the coronary artery imaging of 64-slices multi-detector CT could fulfill the need of the diagnosis, and the radiation dose is apparently lower than the conventional scan.
【摘要】 目的 探讨多层螺旋CT低剂量扫描在小儿上尿路梗阻性疾病中的应用价值。 方法 2008年1月-2009年6月经临床手术证实尿路梗阻的患儿52例，按梗阻的原因分为结石组13例与非结石组39例。将非结石组患儿，按照年龄分为0~1岁（8例）、1~5岁（16例）和5~10岁（15例）3个组，均采用个性化的低剂量扫描方式。 结果 结石组与非结石组阳性诊断率均为100%。低剂量扫描患儿所接受的辐射剂量明显降低，CT扫描管电流不变，管电压降低1/3，CT检查的辐射剂量可降低约70%，且均可达到临床诊断要求。 结论 多层螺旋CT低剂量个性化扫描在小儿上尿路梗阻性疾病中诊断中具有明显优势。【Abstract】 Objective To evaluate low-dose multislice spiral CT for upper urinary tract obstruction in children. Methods From January 2008 to June 2009, 52 children with upper urinary tract obstruction were diagnosed via clinical surgeries. The patients were divided into two groups according to whether having renal calculus (13 patients) or not (39 patients). The patients in non-calculus group were divided into three sub-groups: aged 0-1 (eight patients), 1-5 (16 patients), and 5-10 (15 patients). Low dose multislice spiral CT with different doses was performed. Results The rate of positive predictive diagnosis was 100% in both calculus and non-calculus group. Low dose scan reduced the radiation dose of children. The fixed tube current and the decreased tube voltage (decreased 1/3) led to the decrease of the radiation dose (decreased 70%), which were feasible for diagnosis. Conclusion Low-dose multislice spiral CT was available for upper urinary tract obstruction in children.
【摘要】 目的 研究使用Bowtie滤线器（F1）后，保证加速器CBCT患者扫描图像质量前提下，如何合理设置扫描条件，尽量降低辐射剂量。 方法 使用Piranha辐射测量仪测量CBCT在使用F1与未使用F1时射线的半价层。设定不同的扫描模式，使用直径30 cm的有机玻璃模体测量扫描剂量，并使用XVI附带的Catphan503模体测量客观图像质量。在此基础上，研究扫描剂量以及图像质量与扫描条件的关系，提出了适合临床患者的胸部与腹部不同的扫描条件。 结果 使用F1后射束的半价层增加了0.77～0.92 mmAl，扫描剂量明显减少，中心点减少了22%~29%，边缘点减少了41%~45%，皮肤剂量减少显著。图像质量随着扫描剂量的增大而提高。空间分辨力受FOV影响较大，但一般能识别1～2 mm的物体，完全能够满足分辨细小骨结构与标记点的临床要求。图像伪影在使用L20时的大mAs下明显。胸部低剂量的CBCT图像如100 kV，M20，0.5 mAs的扫描条件亦可满足临床要求。腹部则需要使用较大剂量的扫描模式，CBCT图像才达到进行配准的要求。 结论 F1的使用在改善图像质量的前提下降低了扫描剂量，使用新的扫描序列能平衡二者的关系。【Abstract】 Objective To explore the influence of bowtie filtration on absorb dose and half-value layer inaluminum (Al) of cone-beam CT, estimate the image dose under different scan protocol, and establish the relationship between the image quality and the scan protocol after using F1. Methods Piranha was used to measure the HVL. Dose measurements were performed with an 0.6 cc Farmer type ionization chamber with a 30 cm-diam cylindrical shaped water phantoms in 100 and 120 kV with a series of mAs and FOV. CNR, noise and uniformity were measured on the Catphan503 images. Results HVL increased 0.77-0.92 mmAl where XVI generally had more penetrating beams at the similar kV settings. Scanning dose significantly reduced, the center point decreased 22%-29%, the edge with a decrease of 41%-45% which meant a very significant reduction in skin dose. Image quality improved with mAs increase. The spatial resolution mainly changed with FOV. But generally can identify 1-2 mm-diam objects, fully meet the clinical requirements of identify small bone structure and marker. Through this clinical investigation, low-dose CBCT images in chest, such as 100 kV, M20, and 0.5 mAs scanning protocol appeared to be an optimal settings. Abdomen image needed a higher dose to reach the requirements of registration. Conclusion Using F1 under the premise of improving the image quality then reducing the scanning dose and using a new scanning sequence can balance the image quality and scanning dose.